Replies to post #120159 on Biotech Values

[pcrutch]

Here is a good rundown on the data.

http://pharmastrategyblog.com/2011/05/update-on-denosumab-and-sres-data-from-the-147-trial.html/

[DewDiligence]

AMGN’s own PR on the Xgeva data presented at AUA:

http://finance.yahoo.com/news/Phase-3-Data-Demonstrate-prnews-1018086097.html?x=0&.v=1